Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Immatics Biotechnologies patents

Patents where

Current Assignee

Name

Immatics Biotechnologies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10071148 Immunotherapy against several tumors, such as lung cancer, including NSCLC	Patent 10071148 was granted and assigned to Immatics Biotechnologies on September, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10071148	September 11, 2018
‌ US Patent 11434274 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11434274 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11434274	September 6, 2022
‌ US Patent 11559550 Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers	Patent 11559550 was granted and assigned to Immatics Biotechnologies on January, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11559550	January 24, 2023
‌ US Patent 11541107 Peptides and T cells for use in immunotherapeutic treatment of various cancers		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11541107	January 3, 2023
‌ US Patent 11547750 Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma	Patent 11547750 was granted and assigned to Immatics Biotechnologies on January, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11547750	January 10, 2023
‌ US Patent 11648276 Immunotherapy against neuronal and brain tumors	Patent 11648276 was granted and assigned to Immatics Biotechnologies on May, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11648276	May 16, 2023
‌ US Patent 11559572 Peptides and T cells for use in immunotherapeutic treatment of various cancers		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11559572	January 24, 2023
‌ US Patent 11576954 Method for treating non-small lung cancer with a population of activated cells		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11576954	February 14, 2023
‌ US Patent 10046037 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10046037 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10046037	August 14, 2018
‌ US Patent 10047123 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10047123 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10047123	August 14, 2018
‌ US Patent 10047124 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10047124 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10047124	August 14, 2018
‌ US Patent 10100085 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10100085 was granted and assigned to Immatics Biotechnologies on October, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10100085	October 16, 2018
‌ US Patent 11648292 Immunotherapy against several tumors including gastrointestinal and gastric cancer	Patent 11648292 was granted and assigned to Immatics Biotechnologies on May, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11648292	May 16, 2023
‌ US Patent 11560405 Peptides and combination thereof for use in the immunotherapy against cancers		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11560405	January 24, 2023
‌ US Patent 11466072 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11466072 was granted and assigned to Immatics Biotechnologies on October, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11466072	October 11, 2022
‌ US Patent 11459366 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers	Patent 11459366 was granted and assigned to Immatics Biotechnologies on October, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11459366	October 4, 2022
‌ US Patent 11607446 Personalized immunotherapy against several neuronal and brain tumors	Patent 11607446 was granted and assigned to Immatics Biotechnologies on March, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11607446	March 21, 2023
‌ US Patent 11524059 Personalized immunotherapy against several neuronal and brain tumors	Patent 11524059 was granted and assigned to Immatics Biotechnologies on December, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11524059	December 13, 2022
‌ US Patent 11459371 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11459371 was granted and assigned to Immatics Biotechnologies on October, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11459371	October 4, 2022
‌ US Patent 11440947 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11440947 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11440947	September 13, 2022
‌ US Patent 11434273 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11434273 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11434273	September 6, 2022
‌ US Patent 11433124 Peptides and combination of peptides for use in immunotherapy against various cancers	Patent 11433124 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11433124	September 6, 2022
‌ US Patent 11608370 Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers	Patent 11608370 was granted and assigned to Immatics Biotechnologies on March, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11608370	March 21, 2023
‌ US Patent 11618774 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers	Patent 11618774 was granted and assigned to Immatics Biotechnologies on April, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11618774	April 4, 2023
‌ US Patent 11576955 A*03 restricted peptides for use in immunotherapy against cancers and related methods		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11576955	February 14, 2023

Results per page:

98 results

0 selected

98 results

0 selected